Stryker sells physiotherapy unit, continues focus on ortho/medsurg:
This article was originally published in Clinica
Executive Summary
Consistent with its strategy to divest non-core operations and channel further resources into its main orthopaedic and medical/surgical (medsurg) businesses, orthopaedics company Stryker has sold its physiotherapy business, Physiotherapy Associates (PA), to private equity group Water Street Healthcare Partners for $150m in cash. Kalamazoo, Michigan-based Stryker will record a post-tax gain of $22-26m in the second quarter of 2007 from the sale. PA, which provides a range of outpatient physical therapy services through 475 clinics in 31 US states, brought in revenues of $258.4m and a net profit of $6.3m for Stryker in 2006. However, the company maintains a bullish outlook for its continuing operations, forecasing sales increase of 11-13% for 2007 based on growth in shipments of its orthopaedic implants and medsurg equipment.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.